Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival
© Miller et al; licensee BioMed Central Ltd. 2007
Received: 4 August 2006
Accepted: 12 April 2007
Published: 12 April 2007
Human adenoviruses, such as serotype 5 (Ad5), encode several proteins that can perturb cellular mechanisms that regulate cell cycle progression and apoptosis, as well as those that mediate mRNA production and translation. However, a global view of the effects of Ad5 infection on such programs in normal human cells is not available, despite widespread efforts to develop adenoviruses for therapeutic applications.
We used two-color hybridization and oligonucleotide microarrays to monitor changes in cellular RNA concentrations as a function of time after Ad5 infection of quiescent, normal human fibroblasts. We observed that the expression of some 2,000 genes, about 10% of those examined, increased or decreased by a factor of two or greater following Ad5 infection, but were not altered in mock-infected cells. Consensus k-means clustering established that the temporal patterns of these changes were unexpectedly complex. Gene Ontology terms associated with cell proliferation were significantly over-represented in several clusters. The results of comparative analyses demonstrate that Ad5 infection induces reversal of the quiescence program and recapitulation of the core serum response, and that only a small subset of the observed changes in cellular gene expression can be ascribed to well characterized functions of the viral E1A and E1B proteins.
These findings establish that the impact of adenovirus infection on host cell programs is far greater than appreciated hitherto. Furthermore, they provide a new framework for investigating the molecular functions of viral early proteins and information relevant to the design of conditionally replicating adenoviral vectors.
The Adenoviridae are nonenveloped viruses of mammals and birds that are characterized by linear, double-stranded DNA genomes of 34 to 43 kilobases (kb) and strikingly icosahedral capsids that carry projecting fibers at each of the 12 vertices. Since the first adenovirus was isolated from human adenoid tissue in 1953, some 50 human serotypes have been identified and associated with various syndromes, including upper respiratory tract infections in young children, acute respiratory disease in military recruits, epidemic keratoconjunctivitis, and gastroenteritis. However, it was the demonstration that some human adenoviruses induce tumors in laboratory animals  that greatly increased interest in these viruses and their interactions with host cells. Although human adenoviruses can be classified as highly oncogenic, weakly oncogenic, or non-oncogenic in rodents, all transform rodent cells in culture .
The viral E1A and E1B early genes are necessary and sufficient for transformation, and E1A can also transform normal cells in cooperation with other oncogenes, such as activated RAS . Investigation into the mechanisms by which the E1A and E1B gene products transform cells has yielded important insights into the cellular pathways that control cell cycle progression and programmed cell death, in particular the roles of the tumor suppressor proteins Rb (retinoblastoma protein) and p53 [3–7]. In addition, studies of the viral replication cycle in permissive cells have made major contributions to elucidating fundamental cellular processes, most famously with the discovery of pre-mRNA splicing [8, 9].
The infectious cycle of subgroup C human adenovirus, such as adenovirus type 5 (Ad5), in permissive cells in culture is characterized by a strict temporal program of viral gene expression that culminates in production of large quantities of viral DNA and structural proteins. Viral protein encoding genes are transcribed by the RNA polymerase II transcriptional apparatus of the host, but viral proteins or processes orchestrate the strict temporal sequence in which viral genes are expressed . The first to be transcribed following entry of DNA genomes into host cell nuclei is the E1A immediate early gene. The two most abundant E1A proteins, which are produced by translation of alternatively spliced mRNAs, differ only in the presence in the larger of an internal sequence of 43 amino acids. This segment is one of four E1A protein sequences that are conserved among primate adenoviruses, and denoted conserved region (CR)1 to CR4 [10–12]. It (CR3) is essential for efficient progression beyond the immediate phase of the infectious cycle because it mediates activation of transcription from viral early promoters by the larger E1A protein [13–17]. Such stimulation appears to result from the interaction of CR3 with a subunit of the mediator [18–21], a multiprotein complex that can act as a co-activator or co-repressor of transcription by RNA polymerase II [22, 23].
CR2, which is common to both E1A proteins, probably contributes to activation of transcription of the viral E2 early (E2E) gene. The E2E promoter contains two binding sites for sequence-specific transcriptional activators of the E2F family . The transcriptional functions of E2Fs are regulated by binding of the Rb protein, which represses E2F-dependent transcription [3–5, 25]. A conserved motif within CR2 of E1A proteins binds to the same sequence of the Rb proteins as do E2Fs, and therefore can liberate E2Fs from inhibitory interactions with Rb family members. This interaction of E1A proteins with Rb is necessary for the mitogenic activity of the viral proteins in primary cells, and for their ability to transform nonpermissive cells in conjunction with the viral E1B gene or an activated RAS oncogene [26–31].
Transcription of viral early genes leads to synthesis of some 17 early proteins, many of which perturb host cell (or host) physiology. For example, several E3 proteins block host immune responses [32, 33]. The two E1B proteins can protect infected cells against apoptosis. The E1B 19 kDa protein is a homolog of the cellular antiapoptotic protein Bcl, which inhibits the proapoptotic Bax [3, 4, 34]. In contrast, the E1B 55 kDa protein counters the consequences of activation of the tumor suppressor p53. Binding of this E1B protein to p53 converts the cellular protein from an activator to a repressor of transcription [35, 36] and, in conjunction with the viral E4 orf6 protein, the E1B protein induces accelerated degradation of p53 [37–39]. Once the viral E2 replication proteins have attained sufficient concentrations, viral DNA synthesis commences. This event marks the transition to the late phase of infection and is necessary for activation of the late transcriptional program. Viral DNA synthesis dependent titration of a cellular repressor permits transcription from the promoter of the late IVa2 gene [40, 41], which encodes a sequence-specific DNA-binding protein that has been implicated in stimulation of transcription from the major late (ML) promoter [42, 43]. Transcription from the ML promoter, in conjunction with alternative processing of ML pre-mRNAs, leads to production of some 15 mRNAs, most of which encode viral structural proteins .
As noted above, investigation into interactions among adenoviral and cellular components has greatly improved our understanding of several fundamental processes and the impact of viral gene products on multiple cellular pathways. It has also set the stage for current efforts to develop adenovirus vectors for therapeutic applications. Much effort has been devoted to the design of vectors for delivery of endogenous genes. Within this context a major goal is to minimize host immune responses to the vector, for example by preventing expression of viral genes and viral replication [44–47]. In contrast, the development of conditionally replicating adenoviruses for selective killing of tumor cells depends on efficient replication in transformed but not in normal cells [48–50]. Nevertheless, replication of the virus in normal human cells has received little attention, despite hints of significant differences when Ad5 infects normal as compared to transformed cells. For example, the 243R protein is dispensable for Ad5 replication in transformed HeLa cells, but it is required for maximal replication in normal lung fibroblasts . Similarly, the E1B 55 kDa protein is necessary for efficient viral DNA synthesis in Ad5 infected primary human fibroblasts but not in established lines of human cells . Although informative, such studies of individual viral gene products cannot determine the degree to which interactions of Ad5 with host cell systems differ in established and normal cells. As a first step to address this important issue, we have undertaken a global analysis of the changes in cellular gene expression that accompany progression through the viral infectious cycle in normal human fibroblasts.
Results and discussion
Kinetics of the Ad5 infectious cycle
To provide a temporal framework within which to interpret changes in cellular gene expression induced by Ad5 infection of normal human fibroblasts, we first examined the accumulation of viral DNA, as well as of early and late viral proteins, as a function of time of infection. The results of preliminary experiments were used to design a time series that covered the entire infectious cycle, while focusing on the period (18 to 42 hours after infection) in which synthesis of viral macromolecules and changes in viral gene expression were maximal.
Overview of alterations in cellular gene expression induced by Ad5 infection
We conducted two-color hybridizations using Agilent 44k Whole Genome microarrays to examine time-dependent changes in the concentrations of cellular RNA species in HFFs after Ad5 or mock infection. Infected cells were harvested after various periods of infection, as described above, whereas duplicate samples of mock infected cells were collected at 24 and 48 hours. Zero time point samples for each time course (two zeros for the mock and three for the Ad5 infection) were collected immediately after the 1 hour adsorption period. Labeled cRNAs prepared from Ad5 or mock infected samples (red channel) were hybridized competitively with approximately equal concentrations of a common reference cRNA (green channel). The reference cRNA was made from a mixture of RNAs originating from a diverse set of human cells and cell lines. These differed in terms of history (primary and transformed) and proliferation state (overgrown, cycling, and quiescent), and were chosen in order to maximize the diversity of detectable cellular transcripts, by minimizing the number of probes on the arrays with below-background signals in the reference channel.
For each hybridization, variations in the input of labeled cRNA were corrected by a standard computational dye normalization (see Materials and methods, below). To facilitate comparison of the response profiles of individual probes with each other and with the temporal origin of the experiment, we zero transformed the data by probe; the log2 expression values of each probe in the mock and Ad5 time courses were linearly transformed by subtracting the mean values of the corresponding zero samples. Finally, to isolate a core set of probes that exhibited significant changes in expression specifically in response to Ad5 infection, we applied the following intensity filters; probes were required to exhibit a log2 expression value ≥ 1 (equivalent to 2-fold change) at at least three time points in the Ad5-infected series, and a log2 expression value ≤ 0.4 (equivalent to 1.3-fold change) in no more than two arrays in the mock infected series.
Application of these criteria identified 2,104 genes (unique Unigene clusters), of the 20,590 on the arrays, whose expression exhibited a sustained change of twofold or greater following Ad5 infection, but were not significantly altered in mock infected cells. (For a complete list of genes that pass these filters, see Additional data file 1. The complete unfiltered dataset can be accessed at the Princeton University Microarray database [PUMA] .)
As a comparison with our simple filter for differential expression, we applied significance analysis of microarrays (SAM) . Specifically, we looked for genes that were significantly differentially regulated at two different times after infection, as compared with the triplicate zero time point measurements. To overcome the absence of replicate measurements of Ad5 infected cells, we treated the three measurements surrounding both 26 and 40 hours as triplicate measurements. Two groups of measurements, the first taken at 24, 26, and 28 hours after infection and the second group taken at 38, 40, and 42 hours, were tested independently for differential expression compared with the triplicate zero time point. To make the SAM results comparable with the results of our twofold filter discussed above, we excluded all genes that exhibited any change in response to mock infection. We then performed independent two-class unpaired analysis for the two sets of pseudo-replicates centered at 26 and 40 hours, and combined the results of these two tests. Using a false discovery rate of no more than 0.1%, we identified 5,262 genes that are differentially expressed at 26 or 40 hours after infection. This number far exceeds the 2,104 that pass the fold change filters. In addition, 96% of the genes that pass the fold change filter above were also found by the SAM analysis to exhibit statistically significant differential expression (P < 10-10). Thus, our fold change criteria defined a subset of statistically significantly differentially expressed genes that exhibit the strongest changes in mRNA levels in response to Ad5 infection.
Differences in the methods used to collect and analyze hybridization data are likely to contribute to these seemingly disparate responses to infection, as are the genetic histories of the infected cells. Highly transformed and genetically abnormal cells, such as HeLa cells, are likely to be less sensitive to stresses such as viral infection, and may have lost cellular systems that are targeted by adenovirus in normal diploid fibroblasts. For example, HeLa cells contain integrated copies of the human papillomavirus type 18 oncogenes encoding the E6 and E7 proteins , which, like adenoviral E1B and E1A proteins (see Background, above), inactivate the cellular tumor suppressors p53 and Rb, respectively [57–59]. However, as discussed below, an important determinant of the extent to which cellular gene expression is reprogrammed in Ad5 infected cells appears to be whether cells are proliferating (subconfluent HeLa cells) or quiescent (contact-inhibited HFFs) at the time of infection. In addition to a larger number of responsive genes, our analysis of cellular RNA concentrations at many time points has identified multiple temporal responses to Ad5 infection.
Clustering of co-regulated genes
In order to identify groups of genes that exhibited significant co-regulation, we chose to apply a k-means clustering algorithm to the filtered dataset. The clustering process begins by randomly assigning all genes to k total clusters and computes a centroid vector for each cluster. The algorithm then iteratively reassigns genes to clusters based on the closest match (highest Pearson correlation) of individual expression vectors to the cluster centroids, until no changes allow better matches of gene to cluster means. To ensure that the final clustering result was not sensitive to the initial, random assignment of centroids, we report the consensus of 5,000 such runs of k-means clustering. We determined an appropriate number of clusters, k, by using figure of merit (FOM) analysis, which measures the predictive power of a clustering result by leaving one condition out of the clustering process and measuring how predictive the cluster centroids are of the held-out condition . Details of the consensus clustering are discussed in Materials and methods (below).
Analysis of cellular functions targeted by Ad5 infection
Cellular functions associated with genes significantly regulated by Ad5 infection
GO term ID
GO term description
Cellular functions associated with down-regulated genes
Regulation of transcription
5.97 × e-06
1.63 × e-04
1.05 × e-03
5.42 × e-03
Cellular functions associated with up-regulated genes
< 0.00 × e-11
Ribosome biogenesis and assembly
< 0.00 × e-11
3.60 × e-09
4.73 × e-09
1.71 × e-08
2.03 × e-08
3.52 × e-08
1.12 × e-05
DNA replication initiation
4.37 × e-05
8.81 × e-05
1.86 × e-04
1.95 × e-04
7.92 × e-04
Ribonucleoside monophosphate biosynthesis
4.32 × e-03
Nucleoside monophosphate biosynthesis
7.06 × e-03
Several instances of Ad5-induced co-regulation of genes associated with common cellular functions were identified (Figure 4). Cellular RNAs that increased in concentration slowly and steadily throughout most of the observed infectious cycle, which are grouped in cluster 5, exhibited a highly significant enrichment in RNAs specifying proteins that participate in the establishment and maintenance of chromatin structure (P = 10-8). These RNAs encode chromatin modifying proteins, such as the histone methyl transferase DotIL and subunits of the NuAY histone acetyl transferase, and numerous core histones, including the S-phase specific histone H2BFS. Cluster 1 contains RNAs that increased in abundance early in response to Ad5 infection and remained elevated thereafter. Genes encoding RNA splicing components are significantly enriched in cluster 1 (P = 10-8), and these RNAs encode several snRNP core Sm and Sm-like protein proteins, SF3A subunits, and proteins critical for enhancer mediated splicing. RNAs encoding proteins that mediate nucleocytoplasmic transport of both RNA and protein molecules, such as importins and nucleoporins, were also over-represented in cluster 1 (P = 10-4).
As discussed above, cellular RNAs that exhibited strong, Ad5-induced increases in concentration early in infection (18 to 24 hours) fell into three main kinetic clusters that differ in terms of whether initial increases in RNA concentration were maintained for the duration of the viral life cycle (cluster 1) or steadily declined from 34 hours after infection (clusters 3 and 6). Despite differences in temporal patterns of expression, these clusters exhibited common enrichment in genes ascribed important functions related to cellular proliferation (Figure 4). Both clusters 1 and 3, which are distinguished by whether initial increases in RNA concentration were sustained throughout the infection, were strongly enriched in genes specifying proteins that function in progression through the cell cycle (P = 10-8 in both). These include checkpoint proteins, DNA replication licensing proteins, and cell cycle promoting transcription factors. Enrichment for increased expression of such cell cycle genes is consistent with the well established mitogenic activity of viral E1A proteins (see below). Furthermore, genes encoding proteins that mediate or regulate DNA replication were also highly enriched in clusters 1 and 3 (P = 10-8 in both), as were genes associated with M phase (P = 10-5 and P = 10-4, respectively). These include genes encoding subunits of DNA polymerases, and Mcm complex components, as well as subunits of the anaphase promoting complex, mitotic checkpoint proteins, and proteins that regulate spindle formation, chromosome condensation and chromosome segregation. Interestingly, cluster 3 is also highly enriched for transcripts of DNA repair genes (P < 10-11). In particular, the Fanconi anemia group pathway of DNA repair is heavily targeted by Ad5 infection, as are the central pathways required for the detection and signaling of DNA damage, represented by the catalytic subunit of DNA-dependent protein kinase and the UV damage sensor Rad18. Finally, cluster 6 differs from cluster 3 in that the peak expression levels reached early after infection, subsequently decreased far more dramatically than those in cluster 3, and returned to near baseline levels by 60 hours. Nevertheless, both cluster 3 and 6 are highly enriched for genes involved in another cellular function important for growth and proliferation, namely ribosome biogenesis (P = 10-7 and P = 10-8, respectively). Nucleolar proteins feature prominently in these two clusters, including many that participate in pre-rRNA biosynthesis and maturation, as well as ribosome particle assembly.
Assuming that changes in cellular gene expression induced by Ad5 infection result in corresponding increases or decreases in protein production, and hence activity, we can conclude that the diversity of cellular functions modulated during the adenoviral life cycle is far greater than was previously appreciated. Perhaps even more striking is the substantial enrichment in the 2,000 or so RNAs that changed most strongly in concentration in Ad5-infected HFFs, with those that encode proteins that mediate and regulate cell cycle progression and cell proliferation (Figure 4). Because the HFFs were quiescent at the time of infection, this finding prompted us to undertake a comparison of alterations in gene expression induced by infection and by entry into, and exit from, the quiescent state.
Ad5 infection induces reversal of the quiescence program and recapitulation of the core serum response
Strikingly, genes encoding RNAs that decreased in concentration during quiescence were preferentially upregulated during infection, whereas the transcripts of genes activated during quiescence exhibited nearly systematic Ad5-induced decreases in abundance. To test whether this opposing pattern was statistically significant, we clustered the infection responses into two groups, namely those exhibiting an upward and those exhibiting a downward trend (data not shown), and used the hypergeometric probability distribution to compute P values for the nonrandom representation of quiescence RNAs in each cluster. Downregulated quiescence genes were significantly enriched in the cluster of Ad5 upregulated responses, and upregulated quiescence genes in the cluster of Ad5 downregulated RNAs (P 7 × 10-4 and 9 × 10-5, respectively). Furthermore, the set of genes that did not conform to the reverse pattern (< 30% of the quiescence program genes) generally exhibited weak responses to Ad5 infection and were less than half as likely to pass cutoff filters compared with the set of genes that did conform to the pattern of quiescence reversal. In addition, the several genes that were upregulated both during quiescence and late in Ad5 infection encode proteins (myxovirus resistance protein 2, NF-kappa-B2 [p49/p100], Trim22, and Stat1) that are components of the host antiviral defense mediated by interferon [63, 64].
In all, our findings show a robust reversal of the expression profile recently identified as the core signature of quiescence. The late changes in RNA concentration, and the cellular function of the corresponding genes that do not conform to this reversal, suggest that their increased expression is part of a general response to infection, superimposed on the Ad5-specific reversal of the quiescence program.
Prolonged serum withdrawal represents one way in which quiescence can be induced in primary cells. Upon re-addition of serum, the quiescent state is reversed, and cells re-enter the cell cycle, accompanied by profound changes in their gene expression profile. In fibroblasts, these changes clearly reflect their role in wound healing . The apparent reversal of the quiescence gene expression program induced by Ad5 infection suggested that infection of quiescent fibroblasts by Ad5 may represent an event akin to serum stimulation. To test this hypothesis, we isolated the Ad5 induced changes in expression of the core serum response (CSR) signature genes identified by Chang and coworkers [66, 67]. In remarkable studies, those researchers showed that primary human fibroblasts from different parts of the body exhibit distinct location specific expression profiles , yet they share a common transcriptional response to serum . The latter is termed the CSR, and is defined as the set of 512 genes that, in all 50 fibroblast lines from 10 different anatomical sites, exhibit differential expression when cultured in the presence or absence of serum. Importantly, genes that had been found to show a periodic pattern of altered expression during the cell cycle  were excluded from this list. Thus, the CSR represents a stereotyped, serum dependent gene expression signature, which is independent of cell cycle associated responses to serum.
In addition to providing a molecular fingerprint of fibroblasts that grow in the presence of serum, the transcriptional CSR phenotype has been shown to be a robust predictor of the clinical outcome of several human carcinomas . The metastasis and death associated with these human tumors correlated strongly with expression of the CSR phenotype. Thus, even though adenovirus infection is not tumorigenic in humans, it appears that infection of human cells induces a transcriptional state associated with aggressive tumor progression and poor clinical outcome.
Mechanisms by which Ad5 gene products regulate cellular gene expression
The E1A proteins
Internalization of adenovirus particles by receptor mediated endocytosis is initiated by binding of the capsid penton base to cell surface α 'i integrin molecules . This interaction also results in very rapid (within 10 min), transient activation of phosphoinositide-3-OH kinase . Although activation of signaling via this enzyme has the potential to alter gene expression [70–73], we detected no changes in cellular RNA concentrations during the first hours of the infectious cycle (Figure 4). Rather, the earliest alteration detected took place at 18 hours after infection (Figure 4), coincident with the onset of viral early gene expression (Figure 1). These changes in cellular gene expression are almost certainly the result of changes in rates of transcription; post-transcriptional mechanisms that govern RNA production in Ad5-infected cells operate only late in infection (see Background, above). Furthermore, the adenoviral immediate early E1A proteins, which are necessary for efficient progression beyond the initial phase of the infectious cycle, can regulate transcription by multiple mechanisms. In view of the findings reported above, the effects of CR2 of E1A proteins on cellular E2F proteins were of particular interest.
The E2F transcriptional regulators were first identified, and named, by virtue of their ability to bind specifically to two sites in the type C adenoviral E2 early promoter . This family is now known to comprise at least eight members, which differ in their association with Rb family members, effects on transcription, and mechanisms of binding to DNA [74–78]. For example, E2F-1, E2F-2, and E2F-3 bind directly to the Rb protein and are strong activators of transcription. They are also necessary for activation of E2F-responsive genes and entry into S phase . E2F-4 and E2F-5 can also associate with other members of the Rb family and stimulate transcription less strongly, whereas E2F-6, E2F-7, and E2F-8 appear to repress transcription. Association of E2F proteins with Rb, which inhibits expression of E2F responsive genes, is normally regulated during the cell cycle by phosphorylation of Rb . However, CR2 dependent binding of E1A to Rb protein induces release of E2F, and hence activation of transcription of E2F responsive genes and induction of progression into the S phase of the cell cycle [3, 81, 82]. These effects of CR2, results discussed in the previous section, and the observation that RNAs encoding E2F-1 and E2F-2 increased significantly in concentration from 24 hours after Ad5 infection, whereas E2F-4, E2F-5 and E2F-7 RNAs did not, suggested that E2F-responsive genes were likely to be highly targeted in Ad5 infected HFFs.
A common method used to associate particular transcriptional regulators with induction of specific patterns of gene expression is to search the regulatory sequences of co-regulated genes for statistically significant over-representation of binding sites for such proteins. An initial, manual search of the entire set of genes from positions -1,000 to +500 for the two most common variants of an 8 base pair (bp) E2F consensus binding site [83, 84] identified a large number of potential E2F-responsive genes (some 500). Nearly 80 of these were genes were in clusters 1, 3, and 4, which contain genes specifying RNAs that increased in concentration in response to Ad5 (data not shown). However, in the case of E2F, methods based on identification of binding site sequences are problematic; the currently defined consensus binding sites for members of this family includes a significant degree of degeneracy [83, 84]. Furthermore, it has recently been reported that many sequences to which E2F binds in vivo do not match such consensus sequences . We therefore examined the effects of Ad5 infection on the expression of genes to which E2F family proteins are known to bind in vivo, which have been identified by immunoprecipitation of E2F containing chromatin and microarray analysis of the DNA .
The E2F responsive genes described above represent but a subset of those that increased or decreased in expression during the early phase of Ad5 infection. However, E1A proteins can modulate cellular transcriptional regulators by at least three additional mechanisms. Because the interaction of CR3 of the large E1A protein with the mediator complex (see Background, above) both stimulates transcription by RNA polymerase II in vitro  and is necessary for efficient transcription of viral early genes in infected cells , it may well contribute to activation of cellular gene expression. CR1 and CR4 of the E1A proteins associate with various histone acetylases that activate transcription  and the transcriptional co-repressor Ct-BP [87, 88], respectively. The latter interaction inhibits E1A dependent transformation, whereas CR1 is necessary for transformation. Neither the transcriptional consequences of association of CR1 or CR4 with cellular co-activators or co-repressors, nor the contributions of these E1A sequences to the viral infectious cycle are understood. However, these interactions could well result in either increases or decreases in transcription of specific cellular genes. It will therefore be of interest to examine the effects of substitutions that block the interactions of these conserved regions of E1A proteins with cellular components on cellular gene expression.
The E1B 55 kDa protein
Like E1A proteins, the E1B 55 kDa protein can also modulate cellular gene expression by multiple mechanisms. In terms of molecular detail, the best understood is repression of p53-dependent transcription [35, 36]. Such inhibition of the transcriptional function of this cellular tumor suppressor protein is mediated by binding of the viral protein to the activation domain of p53 [89–91]. The results of in vitro experiments indicate that, when associated with p53, the E1B protein actively represses transcription [89, 90]. It is therefore believed that the carboxyl-terminal repression domain of the E1B 55 kDa protein is recruited to specific promoters via the DNA binding activity of p53 to repress transcription of p53 responsive genes. Consistent with this model, substitutions or insertions at specific positions within the E1B repression domain prevent inhibition of transcription in transient assays or in in vitro reactions [35, 89]. These mutations also impair the ability of the E1B gene to cooperate with E1A in transformation of rodent cells. In addition, it has been reported that the E1B 55 kDa protein inhibits acetylation of p53 by the histone acetyltranferase PCAF , a modification that is important for activation of p53 . The viral protein also prevents stimulation of p53 dependent transcription in transient expression assays by the cellular protein Daxx . However, it is not known whether p53 dependent transcription is repressed during Ad5 infection, as these observations predict. We therefore wished to exploit the data described previously to begin to address this issue.
One of the most remarkable conclusions to emerge from the global analysis of the responses of quiescent fibroblasts to Ad5 infection presented here is that a small number of viral gene products can induce massive reprogramming of cellular gene expression. Even with application of stringent filters, some 10% of the 20,000 or so human genes examined increased or decreased in expression specifically in Ad5 infected cells. Our data also indicate that previously described properties of viral early proteins, such as binding of E1A gene products to Rb family members, are likely to account for the responses of particular sets of cellular genes. Nevertheless, in terms of explanatory power, such well characterized functions of viral proteins represent but the tip of the iceberg, for they apply to no more than 5% of the changes observed. It is probable that effects of activities of viral proteins that are not yet well understood, for example the interaction of CR1 of E1A proteins with cellular transcriptional co-activators, contribute to the reprogramming of cellular gene expression. Secondary consequences of the effects of viral early proteins are also likely to contribute via induction of transcriptional cascades.
It is also apparent that a significant fraction of the alterations in cellular gene expression represent Ad5-induced reversal of the quiescence program with concomitant induction of the core serum response, and activation of expression of many genes associated with cell proliferation. These observations provide the first experimental support for the long-held view that the mitogenic activity of adenoviral E1A proteins, which is crucial for transformation of nonpermissive cells, optimizes the environment of permissive cells for viral replication. Clearly, it will be important in future experiments to examine both cellular responses and progression through the infectious cycle in quiescent fibroblasts infected by viruses carrying mutations that impair specific functions of these viral early proteins. Such information should facilitate design of adenoviral vectors for therapeutic applications.
Materials and methods
Cells and virus
Human Ad5 was propagated in HeLa cells in suspension culture, as described previously ; purified by adsorption to an AdenoPack™ membrane (Sartorius, Goettingen, Germany), in accordance with the manufacturer's instructions; and titered by plaque assay on HeLa cell monolayers . Primary HFFs were maintained in monolayer culture in Dulbecco's modified essential medium (GIBCO-BRL, Gaithersburg, MD, USA) supplemented with 10% (vol/vol) fetal bovine serum (Gemini, West Sacramento, CA, USA). Before Ad5 infection, HFFs were cultured in six-well dishes until 3 days after they had become fully confluent. They were then infected with 30 plaque forming units/cell of Ad5, a multiplicity previously determined to be sufficient for 100% infection of HFFs , or were mock infected. After adsorption of virus for 1 hour at 37°C, the innoculum was removed and replaced with the original, conditioned medium. Mock and Ad5 infected cells were incubated at 37°C.
Analysis of viral DNA and protein synthesis
Infected cells were scraped from individual wells of six-well dishes after various periods of infection, washed twice in ice cold phosphate-buffered saline, and divided into two equal portions. Total DNA was purified from one portion and the quantity of viral DNA examined by using 12 cycles of PCR amplification of a segment of the viral E1A gene, as described previously . The amplified DNA was analyzed by electrophoresis in a 1.4% (weight/vol) agarose gel cast and run in 0.04 M Tris-acetate (pH 7.5) containing 1 mM EDTA. A total protein lysate was prepared from the second portion of each sample of cells, as described previously . The viral early E2 single-stranded DNA-binding protein and late protein V were detected by immunoblotting with monoclonal antibodies B6  and F58#1 , respectively, as described previously .
Analysis of cellular gene expression
Ad5 infected and mock infected HFF cells were harvested for RNA isolation using the RNeasy Micro™ kit (Invitrogen, Carlsbad, CA, USA), following the manufacturer's instructions. In brief, medium was completely removed from wells followed by immediate addition of a denaturing lysis buffer (RLT™, supplied by the manufacturer), homogenization by vortexing, and freezing on dry ice. All samples were thawed and processed for RNA isolation in parallel. The purification included an on-column DNAse I digestion step. The yield and quality of each RNA sample were assessed by nano-drop spectrophotometry and agarose gel electrophoresis, respectively. For each sample, 400 ng RNA was linearly amplified and labeled in the presence of Cy5-CTP, using Low RNA Input Linear Amplification reagents (Agilent Technologies, Santa Clara, CA, USA). Amplified RNA was purified on RNAeasy™ spin columns (Qiagen, Valencia, CA, USA). A mixture of total cellular RNA from five different types of human cells, including both transformed cell lines and primary cells, was labeled with Cy3-CTP and purified in the same way for use as a common reference. The amplification/labeling reactions yielded specific activities of 10 to 12 pmol Cy3/Cy5 per μg cRNA. Samples were processed and hybridized to Agilent Whole Human 44 k DNA microarrays for 17 hours at 60°C in parallel staggered batches using the Agilent hybridization kit. Slides were washed in parallel according to the manufacturer's protocol, which included a final drying rinse in acetonitrile, and scanned in batch using an Agilent two color scanner. All pre- and post-hybridization procedures with labeled cRNAs were performed in an ozone free facility.
Data normalization and processing
Raw image data were extracted using Agilent Feature extraction software with the protocol settings recommended by the manufacturer. Raw channel intensities were adjusted for background using a spatial de-trend algorithm, dye normalization was performed using an intensity-dependent lowness normalization based on spots that passed a rank consistency filter, and final spot values were computed as the log2 of processed channel intensity ratios (red/green). The extracted data were loaded onto the Princeton University PUMA database  for storage and spot quality filtering. Spots flagged by the extraction software as feature uniformity outliers, in either channel, were culled. In addition, only spots flagged as well above background were included in the analysis; uncorrected channel intensity values passed a two sided t-test (P = 0.01) for significance, and background-corrected signals were greater than 2.6 times the standard deviation of global background. Processing of corrected and filtered log2 dye ratio data, including dataset manipulations, zero transformation, filtering, and visualization, were performed using the following freeware: PCL-Analysis (Gavin Scherlock, Stanford University, Palo Alto, CA, USA), TIGR MeV data analysis package, and Java-Treeview (Alok Jerome Saldanha, Stanford University, Palo Alto, CA, USA). Primary probe accessions supplied by Agilent Technologies were mapped to Unigene clusters via batch retrieval using SOURCE  using the Protein Information Resource batch retrieval utility . To establish a dataset of unique genes, the expression values associated with multiple probes referencing the same gene were averaged.
Cellular RNA (100 ng) isolated from HFF cells at 0, 18, 24, 30, 40 and 54 hours after infection (as described in a previous section) was analyzed by RT-PCR for several human genes using the RT-PCR Master Mix (2 ×) kit (USB, Cleveland, OH, USA) in the presence of 3 μCi/reaction [α32P]-dATP (3000 Ci/mmol; Perkin Elmer, Waltham, MA, USA). For each gene, the optimal number of cycles was experimentally determined to ensure exponential amplification. The primer pairs, ranging in size from 19 to 24 bases, were designed to amplify GMNN (positions +68 to +347 of the coding sequence), CCNE1 (+79 to +314), E2F2 (+1,133 to +1,344), MSH2 (+807 to +1,053), SFRP1 (+1,366 to +1,609), FAM45A (+606 to +759), NOLC1 (+639 to +886), LENG9 (+448 to +631), IGFBP5 (+1,208 to +1,445), EIF4EBP2 (+564 to +720), MAP3K3 (+841 to +1,022), PNKP (+519 to +728), RAB31 (+315 to +560), RHOQ (+445 to +601), NEUROG1 (+228 to +379), and CDC6 (+1472 to +1981). The RT-PCR products, ranging in size from about 150 to about 510 base pairs, were resolved by electrophoresis in 6% acrylamide gels, cast, and run in 0.25 × TBE (0.0225 mol/l Tris-borate [pH 7.5], 0.5 mmol/l EDTA). Signals were quantified by using a Molecular Dynamics STORM 869 Phosphor Imaging Scanner and Image Quant™ TL software (Amersham Biosciences, Piscataway, NJ, USA).
Several clustering algorithms, including k-means used here, are sensitive to random initialization. To ensure our clustering result was consistent across different initializations and generally robust, we used consensus clustering . We applied consensus clustering to our data by performing 5,000 iterations of k-means clustering, each with a different, random initialization. We used Pearson correlation as the distance metric with k = 8 (see figure of merit [FOM] discussion, below). For every possible pair of genes, we counted the number of cluster results in which that pair was co-clustered. The final step was to derive a consensus clustering result from the average behavior over the entire set of iterations. We applied the average-linkage agglomerative approach, described by Monit and coworkers , which uses the fraction of iterations in which each pair of genes co-clustered as a similarity metric and builds a hierarchical linkage tree accordingly. Based on FOM analysis (described below), we picked a similarity threshold that resulted in eight total clusters.
One requirement of the k-means algorithm, which is the basis of our consensus clustering, is that a total number of clusters, k, must be chosen in advance. A common approach to automatically determining k is to use FOM analysis, which attempts to ascertain the minimal number of clusters necessary to produce a good fit of the data to the cluster centroids. Specifically, the FOM for a particular choice of clustering parameters (for instance, the number of clusters) is computed by iteratively withholding a single condition from each expression vector, clustering the data, and measuring how predictive cluster centroids are of all member genes' held-out expression measurement . We used the FOM utility in the MeV Tiger toolbox  to perform this analysis and determined that the FOM reached a minimum for k = 8. All figures illustrating clustering results can be interactively viewed on our supplemental website  (clustered data can also be downloaded for viewing with Java-Treeview ).
Gene Ontology enrichment analysis
Gene Ontology (GO) analyses were performed in Matlab using a script written by CLM and DLM based on GO TermFinder . Updated gene association and ontology files were downloaded from the GO Consortium database  on 24 January 2007, and parsed to create a Matlab reference object for the process ontology. These were used to map Uniprot identifiers to their GO process identifiers. The hypergeometric distribution was used to calculate the significance of GO term assignments in gene clusters. The background set of genes was the set of genes represented on the array, and the P values are Bonferroni corrected for multiple hypothesis testing. The Matlab scripts and supporting data can be downloaded from our supplementary website . GO term results were validated and visualized using GOLEM, an interactive tool for browsing the GO .
Additional data files
The following additional data are available with the online version of this paper. Additional file 1 provides dataset shown in Figure 3 (k-means clustered expression data for all genes that pass the fold change and specificity filters). Additional data file 2 shows the validation of microarray data by RT-PCR.
We wish to thank Sanjay Chandriani and John C Matese for invaluable advice and discussion. HAC is grateful for support by the Rita Allen Foundation as a Milton E Cassel Scholar, Center of Excellence Grant P50GM071508 from the National Institute of General Medical Science/National Institutes of Health, and the PhRMA Foundation. SJF is supported by a grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
- Trentin JJ, Yabe Y, Taylor G: The quest for human cancer viruses. Science. 1962, 137: 835-841. 10.1126/science.137.3533.835.PubMedGoogle Scholar
- Shenk T: Adenoviridae and their replication. Virology. Edited by: Fields B, Howley P, Knipe D. 2001, New York, NY: Raven Press, 2265-2300. 4Google Scholar
- Berk AJ: Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene. 2005, 24: 7673-7685. 10.1038/sj.onc.1209040.PubMedGoogle Scholar
- Moran E: DNA tumor virus transforming proteins and the cell cycle. Curr Opin Genet Dev. 1993, 3: 63-70. 10.1016/S0959-437X(05)80342-9.PubMedGoogle Scholar
- Nevins JR: E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 1992, 258: 424-429. 10.1126/science.1411535.PubMedGoogle Scholar
- Frisch SM, Mymryk JS: Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol. 2002, 3: 441-452. 10.1038/nrm827.PubMedGoogle Scholar
- Levine AJ: The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology. 1990, 177: 419-426. 10.1016/0042-6822(90)90505-L.PubMedGoogle Scholar
- Berget SM, Moore C, Sharp PA: Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci USA. 1977, 74: 3171-3175. 10.1073/pnas.74.8.3171.PubMedPubMed CentralGoogle Scholar
- Chow LT, Gelinas RE, Broker TR, Roberts RJ: An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. Cell. 1977, 12: 1-8. 10.1016/0092-8674(77)90180-5.PubMedGoogle Scholar
- Moran E, Mathews MB: Multiple functional domains in the adenovirus E1A gene. Cell. 1987, 48: 177-178. 10.1016/0092-8674(87)90418-1.PubMedGoogle Scholar
- Schaeper U, Subramanian T, Lim L, Boyd JM, Chinnadurai G: Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J Biol Chem. 1998, 273: 8549-8552. 10.1074/jbc.273.15.8549.PubMedGoogle Scholar
- Avvakumov N, Kajon AE, Hoeben RC, Mymryk JS: Comprehensive sequence analysis of the E1A proteins of human and simian adenoviruses. Virology. 2004, 329: 477-492.PubMedGoogle Scholar
- Flint J, Shenk T: Viral transactivating proteins. Annu Rev Genet. 1997, 31: 177-212. 10.1146/annurev.genet.31.1.177.PubMedGoogle Scholar
- Nevins JR: Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell. 1981, 26: 213-220. 10.1016/0092-8674(81)90304-4.PubMedGoogle Scholar
- Jones N, Shenk T: An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci USA. 1979, 76: 3665-3669. 10.1073/pnas.76.8.3665.PubMedPubMed CentralGoogle Scholar
- Ricciardi RP, Jones RL, Cepko CL, Sharp PA, Roberts BE: Expression of early adenovirus genes requires a viral encoded acidic polypeptide. Proc Natl Acad Sci USA. 1981, 78: 6121-6125. 10.1073/pnas.78.10.6121.PubMedPubMed CentralGoogle Scholar
- Berk AJ: Adenovirus promoters and E1A transactivation. Ann Rev Genet. 1986, 20: 45-79. 10.1146/annurev.ge.20.120186.000401.PubMedGoogle Scholar
- Boyer TG, Martin ME, Lees E, Ricciardi RP, Berk AJ: Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature. 1999, 399: 276-279. 10.1038/20466.PubMedGoogle Scholar
- Wang G, Cantin GT, Stevens JL, Berk AJ: Characterization of mediator complexes from HeLa cell nuclear extract. Mol Cell Biol. 2001, 21: 4604-4613. 10.1128/MCB.21.14.4604-4613.2001.PubMedPubMed CentralGoogle Scholar
- Stevens JL, Cantin GT, Wang G, Shevchenko A, Shevchenko A, Berk AJ: Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science. 2002, 296: 755-758. 10.1126/science.1068943.PubMedGoogle Scholar
- Cantin GT, Stevens JL, Berk AJ: Activation domain-mediator interactions promote transcription preinitiation complex assembly on promoter DNA. Proc Natl Acad Sci USA. 2003, 100: 12003-12008. 10.1073/pnas.2035253100.PubMedPubMed CentralGoogle Scholar
- Malik S, Roeder RG: Dynamic regulation of pol II transcription by the mammalian Mediator complex. Trends Biochem Sci. 2005, 30: 256-263. 10.1016/j.tibs.2005.03.009.PubMedGoogle Scholar
- Conaway RC, Sato S, Tomomori-Sato C, Yao T, Conaway JW: The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem Sci. 2005, 30: 250-255. 10.1016/j.tibs.2005.03.002.PubMedGoogle Scholar
- Kovesdi I, Reichel R, Nevins JR: Identification of a cellular transcription factor involved in E1A trans-activation. Cell. 1986, 45: 219-228. 10.1016/0092-8674(86)90386-7.PubMedGoogle Scholar
- Dyson N: The regulation of E2F by pRB-family proteins. Genes Dev. 1998, 12: 2245-2262.PubMedGoogle Scholar
- Howe JA, Mymryk JS, Egan C, Branton PE, Bayley ST: Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc Natl Acad Sci USA. 1990, 87: 5883-5887. 10.1073/pnas.87.15.5883.PubMedPubMed CentralGoogle Scholar
- Stein RW, Corrigan M, Yaciuk P, Whelan J, Moran E: Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J Virol. 1990, 64: 4421-4427.PubMedPubMed CentralGoogle Scholar
- Wang HG, Rikitake Y, Carter MC, Yaciuk P, Abraham SE, Zerler B, Moran E: Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol. 1993, 67: 476-488.PubMedPubMed CentralGoogle Scholar
- Braithwaite AW, Cheetham BF, Li P, Parish CR, Waldron-Stevens LK, Bellett A: Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B. J Virol. 1983, 45: 192-199.PubMedPubMed CentralGoogle Scholar
- Spindler KR, Eng CY, Berk AJ: An adenovirus early region 1A protein is required for maximal viral DNA replication in growth-arrested human cells. J Virol. 1985, 53: 742-750.PubMedPubMed CentralGoogle Scholar
- Zerler B, Roberts RJ, Mathews MB, Moran E: Different functional domains of the adenovirus E1A genes are involved in the regulation of host cell cycle products. Mol Cell Biol. 1987, 7: 821-829.PubMedPubMed CentralGoogle Scholar
- Wold WS, Doronin K, Toth K, Kuppuswamy M, Lichtenstein DL, Tollefson AE: Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Curr Opin Immunol. 1999, 11: 380-386. 10.1016/S0952-7915(99)80064-8.PubMedGoogle Scholar
- Horwitz MS: Adenovirus immunoregulatory genes and their cellular targets. Virology. 2001, 279: 1-8. 10.1006/viro.2000.0738.PubMedGoogle Scholar
- Cuconati A, White E: Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev. 2002, 16: 2465-2478. 10.1101/gad.1012702.PubMedGoogle Scholar
- Teodoro JG, Branton PE: Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J Virol. 1997, 71: 3620-3627.PubMedPubMed CentralGoogle Scholar
- Yew PR, Berk AJ: Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature. 1992, 357: 82-85. 10.1038/357082a0.PubMedGoogle Scholar
- Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ: Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 1998, 17: 554-564. 10.1093/emboj/17.2.554.PubMedPubMed CentralGoogle Scholar
- Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ, Bos JL: The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene. 1998, 16: 349-357. 10.1038/sj.onc.1201540.PubMedGoogle Scholar
- Querido E, Marcellus RC, Lai A, Charbonneau R, Teodoro JG, Ketner G, Branton PE: Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J Virol. 1997, 71: 3788-3798.PubMedPubMed CentralGoogle Scholar
- Iftode C, Flint SJ: Viral synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene. Proc Natl Acad Sci USA. 2004, 101: 17831-17836. 10.1073/pnas.0407786101.PubMedPubMed CentralGoogle Scholar
- Lin HJ, Flint SJ: Identification of a cellular repressor of transcription of the adenoviral late IVa2 gene that is unaltered in activity in infected cells. Virology. 2000, 277: 397-410. 10.1006/viro.2000.0598.PubMedGoogle Scholar
- Tribouley C, Lutz P, Staub A, Kedinger C: The product of the adenovirus intermediate gene IVa2 is a transcription activator of the major late promoter. J Virol. 1994, 68: 4450-4457.PubMedPubMed CentralGoogle Scholar
- Pardo-Mateos A, Young CS: Adenovirus IVa2 protein plays an important role in transcription from the major late promoter in vivo. Virology. 2004, 327: 50-59. 10.1016/j.virol.2004.06.011.PubMedGoogle Scholar
- Benihoud K, Yeh P, Perricaudet M: Adenovirus vectors for gene delivery. Curr Opin Biotechnol. 1999, 10: 440-447. 10.1016/S0958-1669(99)00007-5.PubMedGoogle Scholar
- Basak SK, Kiertscher SM, Harui A, Roth MD: Modifying adenoviral vectors for use as gene-based cancer vaccines. Viral Immunol. 2004, 17: 182-196. 10.1089/0882824041310603.PubMedGoogle Scholar
- Ghosh SS, Gopinath P, Ramesh A: Adenoviral vectors: a promising tool for gene therapy. Appl Biochem Biotechnol. 2006, 133: 9-29. 10.1385/ABAB:133:1:9.PubMedGoogle Scholar
- Verma IM, Weitzman MD: Gene therapy: twenty-first century medicine. Annu Rev Biochem. 2005, 74: 711-738. 10.1146/annurev.biochem.74.050304.091637.PubMedGoogle Scholar
- Lichtenstein DL, Wold WS: Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission. Cancer Gene Ther. 2004, 11: 819-829. 10.1038/sj.cgt.7700765.PubMedGoogle Scholar
- Everts B, van der Poel HG: Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther. 2005, 12: 141-161. 10.1038/sj.cgt.7700771.PubMedGoogle Scholar
- Dobbelstein M: Replicating adenoviruses in cancer therapy. Curr Top Microbiol Immunol. 2004, 273: 291-334.PubMedGoogle Scholar
- Gonzalez R, Huang W, Finnen R, Bragg C, Flint SJ: Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts. J Virol. 2006, 80: 964-974. 10.1128/JVI.80.2.964-974.2006.PubMedPubMed CentralGoogle Scholar
- Princeton University PUMA database. [http://puma.princeton.edu]
- Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001, 98: 5116-5121. 10.1073/pnas.091062498.PubMedPubMed CentralGoogle Scholar
- Zhao LY, Colosimo AL, Liu Y, Wan Y, Liao D: Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx. J Virol. 2003, 77: 11809-11821. 10.1128/JVI.77.21.11809-11821.2003.PubMedPubMed CentralGoogle Scholar
- Granberg F, Svensson C, Pettersson U, Zhao H: Modulation of host cell gene expression during onset of the late phase of an adenovirus infection is focused on growth inhibition and cell architecture. Virology. 2005, 343: 236-245. 10.1016/j.virol.2005.08.023.PubMedGoogle Scholar
- Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985, 314: 111-114. 10.1038/314111a0.PubMedGoogle Scholar
- Helt AM, Galloway DA: Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis. 2003, 24: 159-169. 10.1093/carcin/24.2.159.PubMedGoogle Scholar
- Uhnoo I, Svensson L, Wadell G: Enteric adenoviruses. Baillieres Clin Gastroenterol. 1990, 4: 627-642. 10.1016/0950-3528(90)90053-J.PubMedGoogle Scholar
- Vousden KH: Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol. 1995, 6: 109-116. 10.1006/scbi.1995.0014.PubMedGoogle Scholar
- Yeung KY, Haynor DR, Ruzzo WL: Validating clustering for gene expression data. Bioinformatics. 2001, 17: 309-318. 10.1093/bioinformatics/17.4.309.PubMedGoogle Scholar
- Gene Ontology Consortium. [http://www.geneontology.org]
- Coller HA, Sang L, Roberts JM: A new description of cellular quiescence. PLoS Biol. 2006, 4: e83-10.1371/journal.pbio.0040083.PubMedPubMed CentralGoogle Scholar
- Goodbourn S, Didcock L, Randall RE: Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol. 2000, 81: 2341-2364.PubMedGoogle Scholar
- Hatada EN, Krappmann D, Scheidereit C: NF-kappaB and the innate immune response. Curr Opin Immunol. 2000, 12: 52-58. 10.1016/S0952-7915(99)00050-3.PubMedGoogle Scholar
- Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J, Boguski MS, et al: The transcriptional program in the response of human fibroblasts to serum. Science. 1999, 283: 83-87. 10.1126/science.283.5398.83.PubMedGoogle Scholar
- Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO: Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA. 2002, 99: 12877-12882. 10.1073/pnas.162488599.PubMedPubMed CentralGoogle Scholar
- Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO: Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2004, 2: E7-10.1371/journal.pbio.0020007.PubMedPubMed CentralGoogle Scholar
- Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO, Botstein D: Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell. 2002, 13: 1977-2000. 10.1091/mbc.02-02-0030..PubMedPubMed CentralGoogle Scholar
- Li E, Stupack D, Klemke R, Cheresh DA, Nemerow GR: Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol. 1998, 72: 2055-2061.PubMedPubMed CentralGoogle Scholar
- Bader AG, Kang S, Zhao L, Vogt PK: Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer. 2005, 5: 921-929. 10.1038/nrc1753.PubMedGoogle Scholar
- Martinez-Gac L, Alvarez B, Garcia Z, Marques M, Arrizabalaga M, Carrera AC: Phosphoinositide 3-kinase and Forkhead, a switch for cell division. Biochem Soc Trans. 2004, 32: 360-361. 10.1042/BST0320360.PubMedGoogle Scholar
- Burgering BM, Kops GJ: Cell cycle and death control: long live Forkheads. Trends Biochem Sci. 2002, 27: 352-360. 10.1016/S0968-0004(02)02113-8.PubMedGoogle Scholar
- Brunet A, Datta SR, Greenberg ME: Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol. 2001, 11: 297-305. 10.1016/S0959-4388(00)00211-7.PubMedGoogle Scholar
- Stevaux O, Dyson NJ: A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol. 2002, 14: 684-691. 10.1016/S0955-0674(02)00388-5.PubMedGoogle Scholar
- Giangrande PH, Zhu W, Schlisio S, Sun X, Mori S, Gaubatz S, Nevins JR: A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes Dev. 2004, 18: 2941-2951. 10.1101/gad.1239304.PubMedPubMed CentralGoogle Scholar
- Attwooll C, Oddi S, Cartwright P, Prosperini E, Agger K, Steensgaard P, Wagener C, Sardet C, Moroni MC, Helin K: A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner. J Biol Chem. 2005, 280: 1199-1208. 10.1074/jbc.M412509200.PubMedGoogle Scholar
- Di Stefano L, Jensen MR, Helin K: E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J. 2003, 22: 6289-6298. 10.1093/emboj/cdg613.PubMedPubMed CentralGoogle Scholar
- Guerra S, Lopez-Fernandez LA, Conde R, Pascual-Montano A, Harshman K, Esteban M: Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J Virol. 2004, 78: 5820-5834. 10.1128/JVI.78.11.5820-5834.2004.PubMedPubMed CentralGoogle Scholar
- Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, et al: The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001, 414: 457-462. 10.1038/35106593.PubMedGoogle Scholar
- Hatakeyama M, Weinberg RA: The role of RB in cell cycle control. Prog Cell Cycle Res. 1995, 1: 9-19.PubMedGoogle Scholar
- Nevins JR: Adenovirus E1A: transcription regulation and alteration of cell growth control. Curr Top Microbiol Immunol. 1995, 199: 25-32.PubMedGoogle Scholar
- Adams PD, Kaelin WG: Transcriptional control by E2F. Semin Cancer Biol. 1995, 6: 99-108. 10.1006/scbi.1995.0013.PubMedGoogle Scholar
- Tao Y, Kassatly RF, Cress WD, Horowitz JM: Subunit composition determines E2F DNA-binding site specificity. Mol Cell Biol. 1997, 17: 6994-7007.PubMedPubMed CentralGoogle Scholar
- Kel AE, Kel-Margoulis OV, Farnham PJ, Bartley SM, Wingender E, Zhang MQ: Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. J Mol Biol. 2001, 309: 99-120. 10.1006/jmbi.2001.4650.PubMedGoogle Scholar
- Bieda M, Xu X, Singer MA, Green R, Farnham PJ: Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 2006, 16: 595-605. 10.1101/gr.4887606.PubMedPubMed CentralGoogle Scholar
- Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD: E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev. 2002, 16: 245-256. 10.1101/gad.949802.PubMedPubMed CentralGoogle Scholar
- Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G: A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 1993, 12: 469-478.PubMedPubMed CentralGoogle Scholar
- Chinnadurai G: CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell. 2002, 9: 213-224. 10.1016/S1097-2765(02)00443-4.PubMedGoogle Scholar
- Yew PR, Liu X, Berk AJ: Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 1994, 8: 190-202.PubMedGoogle Scholar
- Martin ME, Berk AJ: Adenovirus E1B 55K represses p53 activation in vitro. J Virol. 1998, 72: 3146-3154.PubMedPubMed CentralGoogle Scholar
- Martin ME, Berk AJ: Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription. Mol Cell Biol. 1999, 19: 3403-3414.PubMedPubMed CentralGoogle Scholar
- Liu Y, Colosimo AL, Yang XJ, Liao D: Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF. Mol Cell Biol. 2000, 20: 5540-5553. 10.1128/MCB.20.15.5540-5553.2000.PubMedPubMed CentralGoogle Scholar
- Prives C: Signaling to p53: breaking the MDM2-p53 circuit. Cell. 1998, 95: 5-8. 10.1016/S0092-8674(00)81774-2.PubMedGoogle Scholar
- Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, Getz G, Domany E, Givol D: DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene. 2001, 20: 2225-2234. 10.1038/sj.onc.1204319.PubMedGoogle Scholar
- Flint SJ, Gallimore PH, Sharp PA: Comparison of viral RNA sequences in adenovirus 2-transformed and lytically infected cells. J Mol Biol. 1975, 96: 47-68. 10.1016/0022-2836(75)90181-3.PubMedGoogle Scholar
- Williams JF: Oncogenic transformation of hamster embryo cells in vitro by adenovirus type 5. Nature. 1973, 243: 162-163. 10.1038/243162a0.PubMedGoogle Scholar
- Gonzalez RA, Flint SJ: Effects of mutations in the adenoviral E1B 55 kDa protein coding sequence on viral late mRNA metabolism. J Virol. 2002, 76: 4507-4519. 10.1128/JVI.76.9.4507-4519.2002.PubMedPubMed CentralGoogle Scholar
- Reich NC, Sarnow P, Duprey E, Levine AJ: Monoclonal antibodies which recognise native and denatured forms of the adenovirus DNA-binding protein. Virology. 1983, 128: 480-484. 10.1016/0042-6822(83)90274-X.PubMedGoogle Scholar
- Lunt R, Vayda ME, Young M, Flint SJ: Isolation and characterization of monoclonal antibodies against the adenovirus core proteins. Virology. 1988, 164: 275-279. 10.1016/0042-6822(88)90645-9.PubMedGoogle Scholar
- SOURCE. [http://smd.stanford.edu/cgi-bin/source/sourceBatchSearch]
- Protein Information Resource. [http://pir.georgetown.edu/pirwww/search/batch.shtml]
- Monti S, Tamayo P, Mesirov J, Golub T: Consensus clustering: a resampling-based method for visualization of gene expression microarray data. Machine Learning. 2003, 52: 91-118. 10.1023/A:1023949509487.Google Scholar
- Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, et al: TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003, 34: 374-378.PubMedGoogle Scholar
- Princeton University PUMA database for Ad5. [http://genomics-pubs.princeton.edu/Ad5_HFF]
- Java Treeview. [http://jtreeview.sourceforge.net]
- Boyle EI, Weng S, Gollub J, Jin H, Botstein D, Cherry JM, Sherlock G: GO:TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics. 2004, 20: 3710-3715. 10.1093/bioinformatics/bth456.PubMedPubMed CentralGoogle Scholar
- Sealfon RS, Hibbs MA, Huttenhower C, Myers CL, Troyanskaya OG: GOLEM: an interactive graph-based gene-ontology navigation and analysis tool. BMC Bioinformatics. 2006, 7: 443-10.1186/1471-2105-7-443.PubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.